Endovascular in situ bypass decreases morbidity and hospital stay following infrainguinal arterial reconstruction.
To report the early results of endovascular in situ saphenous vein bypass (EISVB) using side branch coil occlusion. Between September 1997 and November 1998, 25 patients (15 men; mean age 70.9 years, range 53-85) with lower limb ischemia were treated with endovascular femorodistal bypass. The saphenous vein was prepared using retrograde valvulotomy and endoscopic cannulation with coil occlusion of the side branches. Duplex graft surveillance was performed at 1, 3, 6, and 12 months. The 25 EISVB procedures consisted of 15 femorodistal popliteal, 7 femorotibial, 2 femoroperoneal, and 1 femorodorsalis pedis in situ saphenous vein reconstructions. Mean operative time was 202 +/- 40 minutes, mean number of side branch coils per case was 5.1 +/- 1.3, and mean number of incisions per case was 2.9 +/- 0.6. Mean hospital length of stay (LOS) was 35 +/- 13 hours (1.4 +/- 0.6 days); 19 (76%) patients were discharged on the first postoperative day. Short-term follow-up (mean 6.2 months, range 2-15) was notable for 2 graft thromboses and 1 graft stenosis; primary and secondary patency rates were 88% and 92%, respectively. Three asymptomatic, persistent arteriovenous fistulas discovered on routine duplex were ligated in the outpatient setting. Only 1 (4%) minor wound complication was encountered. EISVB provides early patency comparable to conventional in situ infrainguinal bypass. Its distinct advantages, however, are the ability to minimize incision length with resultant reductions in wound-related complications, hospital LOS, and recovery time. EISVB promises to be a useful adjunct in the approach to peripheral vascular insufficiency.